Vice President, Biochemistry & Biophysics
Artem Evdokimov, Ph.D. is the vice president, biochemistry and biophysics at Silicon Therapeutics. Dr. Evdokimov has experience leading discovery-focused teams at both pharmaceutical and agricultural biotechnology companies where he made contributions in the discovery of two late-stage clinical candidates as well as several transgenic plant traits.
Dr. Evdokimov’s career followed a sinusoidal path from pharma to agricultural biotechnology, with notable stops at Procter & Gamble Pharmaceuticals, Pfizer, and Monsanto. His expertise is split between the discovery of small molecules for pharma and ag-biotech and the design of proteins with useful characteristics (in particular for insect control and herbicide resistance). Dr. Evdokimov is deeply passionate about protein biochemistry and is an expert at building and leading effective cross-functional teams. He has written more than 50 peer-reviewed articles and more than 15 granted U.S. and worldwide patents.
Dr. Evdokimov studied synthetic organic chemistry as an undergraduate at Kiev University, Ukraine and earned a master of science and doctor of philosophy degree in structural biology, protein biochemistry and biophysics at the Weizmann Institute of Science in Rehovot, Israel.